會員登入
註冊
NBI生技指漲跌1.14%、AMEX跌0.58%，NYSE藥業指數跌4.1%。
國際藥廠動態
本週，FDA 緊急許可輝瑞/BNT、莫德納針對Omicron變種BA.4、BA.5的新冠疫苗加強劑，並批准了賽諾菲的罕病藥Xenpozyme。諾華的白血病藥Scemblix在歐洲獲准。| 2022年08月－美股7日漲跌幅排名(0826-0902) | |||||
| 個股代碼 | 名稱 | 本周收價(美元) | 上周收價(美元) | 漲跌幅 | 備註 |
| IBB | iShares Biotechnology ETF | 121.19 | 122.95 | -1.43% | |
| #NBI | NASDAQ生物科技指數 | 3871.4 | 3915.96 | -1.14% | |
| #BTK | AMEX生物科技指數 | 4699.4 | 4726.8 | -0.58% | |
| 個股代碼 | 名稱 | 本周收價(美元) | 上周收價(美元) | 漲跌幅 | 分類 |
| BLUE | bluebird bio | 6.83 | 5.93 | 15.18% | 生技：CART |
| CLLS | Cellectis S.A. | 3.39 | 3.11 | 9.00% | 生技：CART |
| GILD | Gilead Sciences | 63.82 | 62.37 | 2.32% | 生技 |
| AKBA | Akebia Therapeutics | 0.38 | 0.3758 | 1.12% | 製藥(併KERX) |
| CI | Cigna | 287.7 | 284.87 | 0.99% | 醫療保健 |
| AMGN | Amgen | 242.37 | 240.65 | 0.71% | 生技 |
| ABT | Abbott Laboratories | 102.5 | 101.9 | 0.59% | 製藥 |
| MACK | Merrimack Pharmaceuticals | 4.16 | 4.15 | 0.24% | 台灣授權 |
| EDIT | Editas Medicine | 14.83 | 14.83 | 0.00% | 基因編輯 |
| ABBV | AbbVie | 136.28 | 136.35 | -0.05% | 製藥 |
| JNJ | Johnson & Johnson | 162.74 | 164.27 | -0.93% | 製藥 |
| BIIB | Biogen | 196.03 | 198.59 | -1.29% | 生技 |
| SNY | Sanofi | 40.08 | 40.82 | -1.81% | 製藥 |
| PFE | Pfizer | 45.7 | 46.82 | -2.39% | 製藥 |
| REGN | Regeneron Pharmaceuticals | 580.62 | 596.18 | -2.61% | 製藥 |
| MRK | Merck | 86.23 | 89.26 | -3.39% | 製藥：PD-1 |
| NVS | Novartis AG | 79.7 | 82.68 | -3.60% | 製藥 |
| BMY | Bristol-Myers Squibb | 68.61 | 71.19 | -3.62% | 製藥：PD-1 |
| GSK | GSK plc | 31.85 | 33.19 | -4.04% | 製藥 |
| LLY | Eli Lilly and | 301.33 | 315.56 | -4.51% | 製藥 |
| ILMN | Illumina | 196.07 | 205.37 | -4.53% | 生技：醫材 |
| NTLA | Intellia Therapeutics | 56.01 | 58.75 | -4.66% | 基因編輯 |
| CLVS | Clovis Oncology | 1.13 | 1.19 | -5.04% | 製藥：PARP |
| CRSP | CRISPR Therapeutics AG | 63.74 | 67.37 | -5.39% | 基因編輯 |
| TEVA | Teva Pharmaceutical Industries | 8.84 | 9.59 | -7.82% | 製藥 |
| AZN | AstraZeneca PLC | 60.69 | 66.32 | -8.49% | 製藥 |
| ASLN | ASLAN Pharmaceuticals | 0.67 | 0.83 | -19.28% | 製藥(臺美雙掛牌) |
